Medicine
Volume 35, Issue 8 , Pages 438-441 , August 2007

Epidemiology and causes of chronic renal failure

References 

  1. Feest TG, Rajamahesh J, Byrne C, et al. Trends in adult renal replacement therapy in the UK: 1982–2002. QJM. 2005;98:21–28
  2. Ansell D, Feest T, Rao R, Williams A, Winearls C. UK Renal Registry 8th Annual Report. Available at: www.renalreg.com2005;
  3. US Renal Data System . USRDS 2006 Annual Data Report: Atlas of end-stage renal disease in the United States. USRDS; 2006;Available at: www.usrds.org
  4. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1–12
  5. Chadban SJ, Briganti EM, Kerr PG, et al. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol. 2003;14(suppl 2):S131–S138
  6. de Lusignan S, Chan T, Stevens P, et al. Identifying patients with chronic kidney disease from general practice computer records. Fam Pract. 2005;22:234–241
  7. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164:659–663
  8. McKenzie JK, Moss AH, Feest TG, Stocking CB, Siegler M. Dialysis decision making in Canada, the United Kingdom, and the United States. Am J Kidney Dis. 1998;31:12–18
  9. Roderick PJ, Raleigh VS, Hallam L, Mallick NP. The need and demand for renal replacement therapy in ethnic minorities in England. J Epidemiol Community Health. 1996;50:334–339
  10. Hoy W. Renal disease in Australian Aborigines. Nephrol Dial Transplant. 2000;15:1293–1297
  11. Caskey FJ, Roderick P, Steenkamp R, et al. Social deprivation and survival on renal replacement therapy in England and Wales. Kidney Int. 2006;70:2134–2140
  12. Caskey FJ, Schober-Halstenberg HJ, Roderick PJ, et al. Exploring the differences in epidemiology of treated ESRD between Germany and England and Wales. Am J Kidney Dis. 2006;47:445–454
  13. McDonald S, Excell L. Australia and New Zealand Dialysis and Transplant Registry 28th Annual Report. Available at: www.anzdata.org.au2005;
  14. Muntner P, Coresh J, Powe NR, Klag MJ. The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease. J Am Soc Nephrol. 2003;14:1568–1577
  15. Lippert J, Ritz E, Schwarzbeck A, Schneider P. The rising tide of ESRF from diabetic nephropathy type II – and epidemiological analysis. Nephrol Dial Transplant. 1995;10:462–467

PII: S1357-3039(07)00144-2

doi: 10.1016/j.mpmed.2007.05.006

Medicine
Volume 35, Issue 8 , Pages 438-441 , August 2007

Article Tools

* Image Usage & Resolution